Open AccessDo Type and Duration of Antiretroviral Therapy Attenuate Liver Fibrosis in HIV--Hepatitis C Virus--Coinfected Patients?
Author(s) -
Sumita Verma,
ChunHua Wang,
Sugantha Govindarajan,
Gary C. Kanel,
K. Squires,
Maurizio Bonacini
Publication year - 2005
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/499055
Subject(s) - medicine , coinfection , gastroenterology , hepatitis c virus , liver biopsy , hepatitis c , liver disease , fibrosis , biopsy , immunology , human immunodeficiency virus (hiv) , virus
This study aimed to determine whether type and duration of therapy for human immunodeficiency virus (HIV) infection attenuates liver fibrosis in patients with HIV and hepatitis C virus (HCV) coinfection.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom